IBS
Clinical trials for IBS explained in plain language.
Never miss a new study
Get alerted when new IBS trials appear
Sign up with your email to follow new studies for IBS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a tweak in diet plus exercise reverse fatty liver in 3 months?
Disease control CompletedThis study looked at 36 adults with obesity and non-alcoholic fatty liver disease (NAFLD). Participants followed one of two low-calorie Mediterranean diet plans, with different amounts of carbs and fats, plus a moderate exercise program. After 3 months, researchers checked liver …
Matched conditions: IBS
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated May 17, 2026 04:45 UTC
-
Tomato diet shows promise for fatty liver and gut health
Disease control CompletedThis study looked at whether adding tomatoes to the diet can improve liver health, gut function, and blood sugar in people with non-alcoholic fatty liver disease (NAFLD). 80 adults with NAFLD and a BMI of 30 or less took part. Researchers measured liver fat, inflammation, and gut…
Matched conditions: IBS
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
IBS relief for kids? diet study shows promise
Symptom relief CompletedThis study tested whether a low FODMAP diet (limiting certain carbs) can reduce belly pain and other IBS symptoms in children aged 4-18. 70 kids tried both the low FODMAP diet and a standard diet in a crossover design. Researchers also looked at how the diet affects gut bacteria …
Matched conditions: IBS
Phase: NA • Sponsor: University of Bari • Aim: Symptom relief
Last updated May 17, 2026 04:17 UTC
-
Scientists probe gut bugs to unlock IBS Drug's secrets
Knowledge-focused CompletedThis study looked at how tenapanor, a drug for irritable bowel syndrome with constipation (IBS-C), affects the bacteria and chemicals in the gut. Thirty-six adults with IBS-C took tenapanor twice daily for 8 weeks and provided stool samples. The goal was to understand the drug's …
Matched conditions: IBS
Phase: PHASE4 • Sponsor: Kyle Staller, MD, MPH • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC